Tuesday, June 29, 2021

Avid Bioservices Delivers Strong Q4 2021 Results; Expects FY2022 Revenue To Grow 20% - 22%

Avid Bioservices Inc (CDMO), a contract development and manufacturing organization, has reported strong financial results for the fourth quarter and full fiscal year 2021, ended April 30, 2021.

from RTT - Earnings https://ift.tt/3jsKLjC
via IFTTT

No comments:

Post a Comment